NeoTarget™
An AI-enabled target discovery platform

We use AI algorithms to analyze single-cell sequences and multi-omics data for innovative target discovery.

Online analysis software for single-cell sequencing data that has been made available to partners： ZeroCode

NeoBody™
An AI-enabled New Drug Design Platform

On this platform, AI-enabled algorithms can be used for the design of macromolecule drugs, including antibodies, peptides, enzymes, AAVs, etc.

NeoHTS™
A high-throughput wet experiment platform

This is a platform independently developed by Base&Byte, which can greatly improve the efficiency of data output and reduce the cost of data generation.

NeoDesign™
A neoantigen design platform

The platform integrates a variety of AI algorithms to accurately design tumor neoantigens.